On the other hand, the activation of the NLRP3 inflammasome in patients with chronic AIDS maintains the body in a state of chronic inflammation, which adversely affects the recovery of CD4+ T cells during ART treatment and promotes the occurrence of complications, correlating with a poorer prognosis [13,14]. This evidence concerns the gene NLRP3 and AIDS.